12-55492893-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001005519.2(OR6C68):āc.516C>Gā(p.Ile172Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,613,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005519.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR6C68 | NM_001005519.2 | c.516C>G | p.Ile172Met | missense_variant | 1/1 | ENST00000548615.1 | NP_001005519.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR6C68 | ENST00000548615.1 | c.516C>G | p.Ile172Met | missense_variant | 1/1 | NM_001005519.2 | ENSP00000448811 | P1 | ||
ENST00000556750.5 | n.125+198G>C | intron_variant, non_coding_transcript_variant | 2 | |||||||
ENST00000554049.1 | n.89+198G>C | intron_variant, non_coding_transcript_variant | 2 | |||||||
ENST00000555138.1 | n.125+198G>C | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250544Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135402
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461032Hom.: 0 Cov.: 34 AF XY: 0.0000110 AC XY: 8AN XY: 726716
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2021 | The c.516C>G (p.I172M) alteration is located in exon 1 (coding exon 1) of the OR6C68 gene. This alteration results from a C to G substitution at nucleotide position 516, causing the isoleucine (I) at amino acid position 172 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at